JPRN-jRCT2031200156已完成2 期
Phase 2 study of BK1304 in healthy children
Fuji Hideyuki0 个研究点目标入组 120 人开始时间: 2020年10月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 < 13age old（—）
- 性别
- All
入选标准
- •A person who has written informed consent from legal guardian and has obtained an ascent from subject
排除标准
- •History of influenza virus infection or influenza vaccination within 180 days prior to the first dose of study drug
- •History of anaphylaxis to food or drug
- •Judged ineligible for the study by investigator
研究者
相似试验
未知
2 期
Phase II study of BK1304 in healthy adultsPrevention of influenzaJPRN-jRCT2080223352The Research Foundation For Microbial Diseases Of Osaka University600
已完成
3 期
Phase III study of BK1304 in healthy adults and adolescentsPrevention of influenzaJPRN-jRCT2080224074The Research Foundation for Microbial Diseases of Osaka University1,500
未知
3 期
Confirmatory study of BK-4SP in healthy infants.Prophylaxis of pertussis, diphtheria, tetanus, and poliomyelitis infection.JPRN-jRCT2080221090The Research Foundation for Microbial Diseases of Osaka University, Mitsubishi Tanabe Pharma Corporation326
招募中
3 期
Phase 3 study2 of KCI002 in pediatric patientsConstipationJPRN-jRCT2031220631Yoshimura Yuya50
已完成
3 期
Phase 3 study of KCI002 in pediatric patientsConstipationJPRN-jRCT2080224936Kyowa Chemical Industry Co., Ltd.60